相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress
Raffaella Mastrocola et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity
Johan W. E. Jocken et al.
PHYSIOLOGY & BEHAVIOR (2008)
Fiber Type-Specific Nitric Oxide Protects Oxidative Myofibers against Cachectic Stimuli
Zengli Yu et al.
PLOS ONE (2008)
Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients
H. L. Eley et al.
BRITISH JOURNAL OF CANCER (2008)
Postnatal expression of zinc-α2-glycoprotein in rat white and brown adipose tissue
Theodora Tzanavari et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle
Penio T. Todorov et al.
CANCER RESEARCH (2007)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice
C-M Liu et al.
CANCER GENE THERAPY (2007)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Heiko Johnen et al.
NATURE MEDICINE (2007)
The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle
Brian A. Clarke et al.
CELL METABOLISM (2007)
Signaling pathways initiated by β-hydroxy-β-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli
Helen L. Eley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Effect of branched-chain amino acids on muscle atrophy in cancer cachexia
Helen L. Eley et al.
BIOCHEMICAL JOURNAL (2007)
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients
Silvia Busquets et al.
CLINICAL NUTRITION (2007)
Is there a human homologue to the murine proteolysis inducing factor?
Barbara M. Wieland et al.
CLINICAL CANCER RESEARCH (2007)
Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II
S. T. Russell et al.
CELLULAR SIGNALLING (2007)
被撤回的出版物: FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle (Retracted Article. See vol 284, pg 20440, 2009)
Robert J. Southgate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I)
Steven T. Russell et al.
CELLULAR SIGNALLING (2007)
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia?: Role of β2-adrenergic agonists
Gemma Fuster et al.
CANCER RESEARCH (2007)
Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis
Mikael Ryden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia
Mark D. DeBoer et al.
ENDOCRINOLOGY (2007)
Mechanism of increased lipolysis in cancer cachexia
Thorhallur Agustsson et al.
CANCER RESEARCH (2007)
Insulin treatment in cancer cachexia:: Effects on survival, metabolism, and physical functioning
Kent Lundholm et al.
CLINICAL CANCER RESEARCH (2007)
NF-κB is important for TNF-α-induced lipolysis in human adipocytes
Jurga Laurencikiene et al.
JOURNAL OF LIPID RESEARCH (2007)
Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase
H. L. Eley et al.
BRITISH JOURNAL OF CANCER (2007)
Signalling to translation: how signal transduction pathways control the protein synthetic machinery
Christopher G. Proud
BIOCHEMICAL JOURNAL (2007)
Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation
Helen L. Eley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Analysis of lipolytic protein trafficking and interactions in adipocytes
James G. Granneman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Lipolysis is altered in MHC class I zinc-α2-glycoprotein deficient mice
Veronique Rolli et al.
FEBS LETTERS (2007)
Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy
H. Gilson et al.
ENDOCRINOLOGY (2007)
Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism
Helene Pelicano et al.
JOURNAL OF CELL BIOLOGY (2006)
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism
Craig McFarlane et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice
C. Bing et al.
BRITISH JOURNAL OF CANCER (2006)
The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression
Behrouz Salehian et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
The p38 MAPK signaling pathway: A major regulator of skeletal muscle development
Aviad Keren et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy
Florian L. Muller et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
DAC Deans et al.
BRITISH JOURNAL OF CANCER (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients
I Wolf et al.
CANCER (2006)
The AP-1/CJUN signaling cascade is involved in muscle differentiation:: Implications in muscle wasting during cancer cachexia
R Moore-Carrasco et al.
FEBS LETTERS (2006)
Angiotensin II directly inhibits protein synthesis in murine myotubes
ST Russell et al.
CANCER LETTERS (2006)
The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer
A Jatoi et al.
DISEASES OF THE ESOPHAGUS (2006)
Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss
Maurizio Bossola et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia
S Acharyya et al.
CANCER CELL (2005)
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
J Khal et al.
BRITISH JOURNAL OF CANCER (2005)
Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight
J Khal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects
I Dahlman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia
PM Sanders et al.
BRITISH JOURNAL OF CANCER (2005)
NF-κB-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release
S Di Marco et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia
ST Russell et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group
A Jatoi et al.
SUPPORTIVE CARE IN CANCER (2005)
Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care -: Correlations with food intake, metabolism, exercise capacity, and hormones
M Fouladiun et al.
CANCER (2005)
Increased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia
UA Unmehopa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
JN Gordon et al.
GUT (2005)
The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia
ST Russell et al.
BRITISH JOURNAL OF CANCER (2005)
Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3
W Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle
YP Li et al.
FASEB JOURNAL (2005)
NF-κB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle
SM Wyke et al.
BRITISH JOURNAL OF CANCER (2005)
Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle
A Chand et al.
CANCER LETTERS (2005)
eIF2 and the control of cell physiology
CG Proud
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake involvement of ROS in a model of mouse cancer cachexia
S Busquets et al.
FEBS LETTERS (2005)
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway
E Latres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Zinc-α2-glycoprotein, a lipid mobilizing factor, and is expressed and secreted by human (SGBS) adipocytes
Y Bao et al.
FEBS LETTERS (2005)
Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes
SM Wyke et al.
CELLULAR SIGNALLING (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage
PM Sanders et al.
BRITISH JOURNAL OF CANCER (2004)
Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients
MJ Dooley et al.
BRITISH JOURNAL OF CANCER (2004)
Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein
ST Russell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2004)
Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia
C Bing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of protein synthesis by branched-chain amino acids in vivo
F Yoshizawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control
Y Kamei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting
S Busquets et al.
CANCER RESEARCH (2004)
Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia
CL Monitto et al.
CLINICAL CANCER RESEARCH (2004)
Effect of zinc-α2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue
PM Sanders et al.
CANCER LETTERS (2004)
Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area
EA Isenring et al.
BRITISH JOURNAL OF CANCER (2004)
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
V Kedar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer
DJ McKeown et al.
BRITISH JOURNAL OF CANCER (2004)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by β-hydroxy-β-methylbutyrate
HJ Smith et al.
CANCER RESEARCH (2004)
Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue
SA Beck et al.
LIPIDS (2004)
The proteasome: a proteolytic nanomachine of cell regulation and waste disposal
DH Wolf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3α-II during cancer cachexia
KS Kwak et al.
CANCER RESEARCH (2004)
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort
A Jatoi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation
SM Wyke et al.
BRITISH JOURNAL OF CANCER (2004)
Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy
KMV Lai et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial
NM Neary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
IKKβ/NF-κB activation causes severe muscle wasting in mice
DS Cai et al.
CELL (2004)
Targets for TNF-α-induced lipolysis in human adipocytes
M Rydén et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
PJ Ross et al.
BRITISH JOURNAL OF CANCER (2004)
Role of protein kinase C and NF-κB in proteolysis-inducing factor-induced proteasome expression in C2C12 myotubes
HJ Smith et al.
BRITISH JOURNAL OF CANCER (2004)
The relationship between a urinary cachectic factor and weight loss in advanced cancer patients
ML Williams et al.
CANCER INVESTIGATION (2004)
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
KCH Fearon et al.
GUT (2003)
A neural survival factor is a candidate oncogene in breast cancer
D Porter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB
AS Whitehouse et al.
BRITISH JOURNAL OF CANCER (2003)
Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia
ZJ Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale
JE Tranmer et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2003)
Glucose metabolism in cancer - Evidence that demethylation events play a role in activating type II hexokinase gene expression
A Goel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass
ZH Khan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products
KJ Ladner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tumor necrosis factor-α stimulates lipolysis in differentiated human Adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP
HH Zhang et al.
DIABETES (2002)
The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation
SL Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo
ST Russell et al.
BRITISH JOURNAL OF CANCER (2002)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
Leptin role in advanced lung cancer.: A mediator of the acute phase response or a marker of the status of nutrition?
MR Alemán et al.
CYTOKINE (2002)
Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress
MCC Gomes-Marcondes et al.
CANCER LETTERS (2002)
Induction of cachexia in mice by systemically administered myostatin
TA Zimmers et al.
SCIENCE (2002)
Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes
TM Watchorn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Reversal of cancer-related wasting using oral supplementation with a combination of β-hydroxy-β-methylbutyrate, arginine, and glutamine
PE May et al.
AMERICAN JOURNAL OF SURGERY (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans
P Collins et al.
BRITISH JOURNAL OF CANCER (2002)
Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor
ST Russell et al.
BRITISH JOURNAL OF CANCER (2002)
C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle
G Penner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Molecular regulation of muscle cachexia: It may be more than the proteasome
PO Hasselgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Mitochondrial DNA alterations in cancer
WC Copeland et al.
CANCER INVESTIGATION (2002)
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
MD Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dermcidin: a novel human antibiotic peptide secreted by sweat glands
B Schittek et al.
NATURE IMMUNOLOGY (2001)
Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway
AS Greenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer
AP John
MEDICAL HYPOTHESES (2001)
Hyperlipemia:: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia?
S Busquets et al.
FEBS LETTERS (2001)
Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)
B Islam-Ali et al.
BRITISH JOURNAL OF CANCER (2001)
Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients
I Bosaeus et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)
MJ Lorite et al.
BRITISH JOURNAL OF CANCER (2001)
Insulin resistance in patients with cancer: Relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure
T Yoskikawa et al.
NUTRITION (2001)
Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation
BS Islam-Ali et al.
BRITISH JOURNAL OF CANCER (2001)
The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia
AQ Adigun et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Hypersensitization of tumor cells to glycolytic inhibitors
H Liu et al.
BIOCHEMISTRY (2001)
Using positron emission tomography with [18F]FDG to predict tumor behavior in experimental colorectal cancer
BM Burt et al.
NEOPLASIA (2001)
Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia
JE Belizário et al.
BRITISH JOURNAL OF CANCER (2001)
Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia
P Costelli et al.
BRITISH JOURNAL OF CANCER (2001)
High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: A systematic review of randomised clinical trials
M Maltoni et al.
ANNALS OF ONCOLOGY (2001)
Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance
DS Ludwig et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Managing cancer-related anorexia/cachexia
G Mantovani et al.
DRUGS (2001)
Apoptosis of muscle cells causes weight loss prior to impairment of DNA synthesis in tumor-bearing rabbits
O Ishiko et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation
PO Hasselgren et al.
ANNALS OF SURGERY (2001)
Down-regulation of uncoupling protein-3 and-2 by thiazolidinediones in C2C12 myotubes
A Cabrero et al.
FEBS LETTERS (2000)
Tumor necrosis factor-α generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade
CH Woo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
NF-κB-induced loss of MyoD messenger RNA:: Possible role in muscle decay and cachexia
DC Guttridge et al.
SCIENCE (2000)
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
DR Ferry et al.
ANNALS OF ONCOLOGY (2000)
DNA fragmentation occurs in skeletal muscle during tumor growth:: A link with cancer cachexia?
M van Royen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
